Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer

Journal of Clinical Virology

Volumn 61, Issue 1, 2014, Pages 94-100

  Um, Sung Ho ^a   Mundi, Neil ^a   Yoo, John ^a,b   Palma, David A ^a,b,c   Fung, Kevin ^a,b   MacNeil, Danielle ^a,b   Wehrli, Bret ^a   Mymryk, Joe S ^a,b,c   Barrett, John W ^a,b,c   Nichols, Anthony C ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

E5; EGFR; Human papillomavirus; Oropharyngeal cancer; Viral oncogene

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; BIOLOGICAL MARKER; EGFR PROTEIN, HUMAN; ONCOPROTEIN; VIRUS PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER STAGING; CELL SURFACE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; ONCOGENE E5; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SMOKING; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; WART VIRUS; AGED; BIOSYNTHESIS; COMPLICATION; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; SURVIVAL; UNITED KINGDOM; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LONDON; MALE; MIDDLE AGED; ONCOGENE PROTEINS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VIRAL PROTEINS;

EID: 84905117252     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.06.019     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011, 29:4294-4301.
3. Nichols A.C., Palma D.A., Dhaliwal S.S., Tan S., Thuerer J., Chow W., et al. The epidemic of human papillomavirus and oropharyngeal cancer in a Canadian population. Curr Oncol 2013, 20:212-219.
4. Ang K.K., Harris J., Wheeler R., Weber R., Rosenthal D.I., Nguyen-Tan P.F., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Eng J Med 2010, 363:24-35.
5. Gillison M.L. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004, 31:744-754.
6. Jegu J., Binder-Foucard F., Borel C., Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 2013, 49:9-14.
7. Price K.A., Cohen E.E. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol 2012, 13:35-46.
8. Cardesa A., Nadal A. Carcinoma of the head and neck in the HPV era. Acta dermatovenerol Alp Panonica Adriat 2011, 20:161-173.
9. O'Sullivan B., Huang S.H., Siu L.L., Waldron J., Zhao H., Perez-Ordonez B., et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol 2013, 31:543-550.
10. Narisawa-Saito M., Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci 2007, 98:1505-1511.
11. DiMaio D., Mattoon D. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 2001, 20:7866-7873.
12. Lewis C., Baro M.F., Marques M., Gruner M., Alonso A., Bravo I.G. The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth. Virol J 2008, 5:30.
13. Leechanachai P., Banks L., Moreau F., Matlashewski G. The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. Oncogene 1992, 7:19-25.
14. Straight S.W., Herman B., McCance D.J. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995, 69:3185-3192.
15. Chung C.H., Gillison M.L. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009, 15:6758-6762.
16. Lorenzon L., Mazzetta F., Venuti A., Frega A., Torrisi M.R., French D. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix. J Clin Virol 2011, 52:79-83.
17. Gold K.A., Kim E.S. Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol 2009, 21:206-211.
18. Zhu X., Zhang F., Zhang W., He J., Zhao Y., Chen X. Prognostic role of epidermal growth factor receptor in head and neck cancer: a meta-analysis. J Surg Oncol 2013.
19. Kumar B., Cordell K.G., Lee J.S., Worden F.P., Prince M.E., Tran H.H., et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008, 26:3128-3137.
20. Nichols A.C., Dhaliwal S.S., Palma D.A., Basmaji J., Chapeskie C., Dowthwaite S., et al. Does HPV type affect outcome in oropharyngeal cancer?. J Otolaryngol Head Neck Surg 2013, 42:9.
21. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008, 100:261-269.
22. Nichols A.C., Faquin W.C., Westra W.H., Mroz E.A., Begum S., Clark J.R., et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol - Head Neck Surg 2009, 140:228-234.
23. Nichols A.C., Kneuertz P.J., Deschler D.G., Lin D.T., Emerick K.S., Clark J.R., et al. Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck 2011, 33:516-524.
24. Dimaio D., Petti L.M. The E5 proteins. Virology 2013, 445:99-114.
25. Huotari J., Helenius A. Endosome maturation. EMBO J 2011, 30:3481-3500.
26. Suprynowicz F.A., Krawczyk E., Hebert J.D., Sudarshan S.R., Simic V., Kamonjoh C.M., et al. The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J Virol 2010, 84:10619-10629.
27. Straight S.W., Hinkle P.M., Jewers R.J., McCance D.J. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J Virol 1993, 67:4521-4532.
28. Pim D., Collins M., Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992, 7:27-32.
29. Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M.R., et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16.
30. Genther Williams S.M., Disbrow G.L., Schlegel R., Lee D., Threadgill D.W., Lambert P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 2005, 65:6534-6542.
31. DiGiovanna M.P., Lerman M.A., Coffey R.J., Muller W.J., Cardiff R.D., Stern D.F. Active signaling by Neu in transgenic mice. Oncogene 1998, 17:1877-1884.
32. Nicholson R.I., Gee J.M., Harper M.E. EGFR and cancer prognosis. Eur J Cancer 2001, 37(Suppl 4):S9-15.
33. Kalyankrishna S., Grandis J.R. Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 2006, 24:2666-2672.
34. Nichols A.C., Yoo J., Hammond J.A., Fung K., Winquist E., Read N., et al. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR) - study protocol for a randomized phase II trial. BMC Cancer 2013, 13:133.
35. Quon H., Richmon J.D. Treatment deintensification strategies for HPV-associated head and neck carcinomas. Otolaryngol Clin North Am 2012, 45:845-861.
36. O'Sullivan B., Huang S.H., Perez-Ordonez B., Massey C., Siu L.L., Weinreb I., et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 2012, 103:49-56.